EPCAM and ovarian neoplasm: To evaluate the in vivo relevance of resistance to platinum chemotherapy in EpCAM-positive cancer cells, iMOT cells were orthotopically transplanted into immunocompetent recipient mice, and recipient mice bearing ovarian tumors received intraperitoneal cisplatin or carboplatin treatment (Figure 3A).